前沿论道|mCRPC骨转移核素治疗新进展—ALSYMPCA研究解读 40571 观看发布时间 2020-08-27 课程介绍 讲者介绍
ALSYMPCA Trial: Updated Analysis of Survival With Radium-223 Treatment in Metastatic Prostate CancerMatthew Stenger
PCN74聽鈥撀燙ost-Effectiveness of Radium-223 Dichloride (Radium-223) In Alsympca: A Cost-Effectiveness Analysis of Radium-223+Best Standard of Care (Bsoc) Compared With Placebo+Bsoc In Treatment of Castration-Resistant Prostate Cancer (Crpc) And Symptomatic Bone Metastases In Canada...
Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial Author links open overlay panelChristopher Parker a, Steven E. Finkelstein b, Jeff M. Michalski c, Joe M. O'Sullivan d, ...
摘要: 770PREASONS FOR PATIENTS (PTS) DISCONTINUING STUDY TREATMENT (TX) IN THE PHASE 3 ALSYMPCA TRIAL OF RADIUM-223 DICHLORIDE (RA-223) IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC) WITH BONE METASTASES (METS)DOI: 10.1093/annonc/mdu336.18 被引量: 1 ...
PD24-07 EFFICACY AND SAFETY OF RADIUM-223 BY RADICAL LOCAL THERAPY AT INITIAL DIAGNOSIS: A RETROSPECTIVE SUBGROUP ANALYSIS OF ALSYMPCA TRIAL 来自 学术范 喜欢 0 阅读量: 7 作者:L Klotz,C Sweeney,A Dicker,N Vogelzang,M Morris,F Verholen,V Wagner,C Lu,C Parker,O Sartor ...
Radium-223 prolongs overall survival in patients with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases, regardless of prior docetaxel. Whether or not chemotherapy can be safely administered following radium-223 treatment is of clinical importa...
EBRT Use and Safety with Radium-223 in Patients with CRPC and Symptomatic Bone Metastases from the ALSYMPCA Trial Professor Sartor presents results from the ALSYMPCA trial which showed radium-223 significantly reduced the risk of EBRT use for bone pain while significant...
Purpose/Objective(s) Radium-223 chloride (Ra-223), a targeted alpha-emitter, is a calcium mimetic that targets bone metastases with high-energy alpha-particles of extremely short range ( < 100 渭m). ALSYMPCA, the phase III, double-blind, randomized, multinational study, was designed to ...
Chemotherapy following radium-223 dichloride treatment in ALSYMPCA. Prostate 2016; 76:905-16.Sartor O, et al. Chemotherapy following radium-223 dichloride treatment in ALSYMPCA. Prostate. 2016;76(10):905-16.Sartor O, Hoskin P, Coleman RE, Nilsson S, Vogelzang NJ, Petrenciuc O, Staudacher ...